The human gut microbiome in early-onset type 1 diabetes from the TEDDY study

Nature

Volumn 562, Issue 7728, 2018, Pages 589-594

  Vatanen, Tommi ^a   Franzosa, Eric A ^a,b   Schwager, Randall ^b   Tripathi, Surya ^a   Arthur, Timothy D ^a   Vehik, Kendra ^c   Lernmark, Åke ^d   Hagopian, William A ^e   Rewers, Marian J ^f   She, Jin Xiong ^g   Toppari, Jorma ^h,i   Ziegler, Anette G ^j,k   Akolkar, Beena ^l   Krischer, Jeffrey P ^c   Stewart, Christopher J ^m,n   Ajami, Nadim J ^m   Petrosino, Joseph F ^m   Gevers, Dirk ^a,r   Lähdesmäki, Harri ^o   Vlamakis, Hera ^a   Huttenhower, Curtis ^a,b   Xavier, Ramnik J ^a,p,q   more..

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d LUND UNIVERSITY   (Sweden)

^e PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF COLORADO DENVER   (United States)

^g MEDICAL COLLEGE OF GEORGIA   (United States)

^h TURKU UNIVERSITY HOSPITAL   (Finland)

ⁱ UNIVERSITY OF TURKU   (Finland)

^j INSTITUTE OF EPIDEMIOLOGY   (Germany)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^l NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^m BAYLOR COLLEGE OF MEDICINE   (United States)

ⁿ NEWCASTLE UNIVERSITY   (United Kingdom)

^o AALTO UNIVERSITY   (Finland)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

^q MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^r JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; OLIGOSACCHARIDE; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; VOLATILE FATTY ACID;

ANTIBIOTIC THERAPY; BACTERIAL GENOME; BACTERIAL INFECTION; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BREAST FEEDING; BREAST MILK; CAUCASIAN; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FATTY ACID SYNTHESIS; FECES; FEMALE; FERMENTATION; GEOGRAPHY; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; LETTER; MAJOR CLINICAL STUDY; MALE; MICROBIOME; NONHUMAN; PANCREAS ISLET BETA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEOBACTERIA; ANIMAL; BIFIDOBACTERIUM; DISEASE MODEL; ENZYMOLOGY; GENETICS; HEALTH SURVEY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MICROBIOLOGY; MOUSE; ONSET AGE; PANCREAS ISLET; PHYSIOLOGY; AUTOIMMUNITY; BACTERIAL STRAIN; CASE CONTROL STUDY; FECES ANALYSIS; GENE; HISPANIC; METAGENOME; PATHOGENESIS; PHYLUM; TAXONOMY;

BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; PROTEOBACTERIA;

AGE OF ONSET; ANIMALS; BIFIDOBACTERIUM; BREAST FEEDING; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS, VOLATILE; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HEALTH SURVEYS; HUMANS; INFANT; ISLETS OF LANGERHANS; LONGITUDINAL STUDIES; MALE; MICE; MILK, HUMAN; PROTEOBACTERIA;

EID: 85055415843     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-018-0620-2     Document Type: Article

References (52)

1. Katsarou, A. et al. Type 1 diabetes mellitus. Nat. Rev. Dis. Primers 3, 17016 (2017).
2. Pociot, F. & Lernmark, Å. Genetic risk factors for type 1 diabetes. Lancet 387, 2331–2339 (2016).
3. Rewers, M. & Ludvigsson, J. Environmental risk factors for type 1 diabetes. Lancet 387, 2340–2348 (2016).
4. Knip, M. & Siljander, H. The role of the intestinal microbiota in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 12, 154–167 (2016).
5. Hober, D. & Sauter, P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol. 6, 279–289 (2010).
6. Paun, A., Yau, C. & Danska, J. S. The influence of the microbiome on type 1 diabetes. J. Immunol. 198, 590–595 (2017).
7. de Goffau, M. C. et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 57, 1569–1577 (2014).
8. de Goffau, M. C. et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 62, 1238–1244 (2013).
9. Mariño, E. et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat. Immunol. 18, 552–562 (2017).
10. Needell, J. C. & Zipris, D. The role of the intestinal microbiome in type 1 diabetes pathogenesis. Curr. Diab. Rep. 16, 89 (2016).
11. Davis-Richardson, A. G. et al. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front. Microbiol. 5, 678 (2014).
12. Kostic, A. D. et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17, 260–273 (2015).
13. Endesfelder, D. et al. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63, 2006–2014 (2014).
14. Maffeis, C. et al. Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes. Diabetes Metab. Res. Rev. 32, 700–709 (2016).
15. Mejía-León, M. E., Petrosino, J. F., Ajami, N. J., Domínguez-Bello, M. G. & de la Barca, A. M. Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci. Rep. 4, 3814 (2014).
16. Alkanani, A. K. et al. Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes 64, 3510–3520 (2015).
17. Soyucen, E. et al. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr. Int. 56, 336–343 (2014).
18. Endesfelder, D. et al. Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production. Microbiome 4, 17 (2016).
19. Zhao, L. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151–1156 (2018).
20. Markle, J. G. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084–1088 (2013).
21. Costa, F. R. et al. Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. J. Exp. Med. 213, 1223–1239 (2016).
22. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012).
23. Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A. & Brown, P. O. Development of the human infant intestinal microbiota. PLoS Biol. 5, e177 (2007).
24. Koenig, J. E. et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl Acad. Sci. USA 108, 4578–4585 (2011).
25. Dominguez-Bello, M. G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107, 11971–11975 (2010).
26. Bäckhed, F. et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 690–703 (2015).
27. Yassour, M. et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci. Transl. Med. 8, 343ra81 (2016).
28. Hagopian, W. A. et al. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr. Diabetes 12, 733–743 (2011).
29. Lee, H. S. et al. Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Metab. Res. Rev. 30, 424–434 (2014).
30. Stewart, C. J. et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 10.1038/s41586-018-0617-x (2018).
31. Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
32. Korpela, K. et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Commun. 7, 10410 (2016).
33. Joice, R., Yasuda, K., Shafquat, A., Morgan, X. C. & Huttenhower, C. Determining microbial products and identifying molecular targets in the human microbiome. Cell Metab. 20, 731–741 (2014).
34. Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25–29 (2000).
35. O’Callaghan, A. & van Sinderen, D. Bifidobacteria and their role as members of the human gut microbiota. Front. Microbiol. 7, 925 (2016).
36. Thurston, B., Dawson, K. A. & Strobel, H. J. Pentose utilization by the ruminal bacterium Ruminococcus albus. Appl. Environ. Microbiol. 60, 1087–1092 (1994).
37. Uusitalo, U. et al. Association of early exposure of probiotics and islet autoimmunity in the TEDDY Study. JAMA Pediatr. 170, 20–28 (2016).
38. Underwood, M. A., German, J. B., Lebrilla, C. B. & Mills, D. A. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr. Res. 77, 229–235 (2015).
39. Sela, D. A. et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl Acad. Sci. USA 105, 18964–18969 (2008).
40. Vatanen, T. et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 842–853 (2016).
41. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatr. Diabetes 8, 286–298 (2007).
42. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann. NY Acad. Sci. 1150, 1–13 (2008).
43. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care 38, S8–S16 (2015).
44. Lachin, J. M. Sample size evaluation for a multiply matched case–control study using the score test from a conditional logistic (discrete Cox PH) regression model. Statist. Med. 27, 2509–2534 (2012).
45. Schmieder, R. & Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 27, 863–864 (2011).
46. Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902–903 (2015).
47. Abubucker, S. et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLOS Comput. Biol. 8, e1002358 (2012).
48. Huang, K. et al. MetaRef: a pan-genomic database for comparative and community microbial genomics. Nucleic Acids Res. 42, D617–D624 (2014).
49. Suzek, B. E., Wang, Y., Huang, H., McGarvey, P. B. & Wu, C. H. UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches. Bioinformatics 31, 926–932 (2015).
50. Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res. 44, D471–D480 (2016).
51. The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 45, D158–D169 (2017).
52. Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).